Jane Street’s Array Biopharma Inc ARRY Stock Holding History

Jane Street’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-29,300	Closed	-$715K	–	6113
2019 Q1	$715K	Buy	+29,300	New	+$610K	﹤0.01%	3221
2018 Q3	–	Sell	-26,000	Closed	-$436K	–	6034
2018 Q2	$436K	Buy	26,000 +13,000	+100%	+$207K	﹤0.01%	3735
2018 Q1	$212K	Buy	+13,000	New	+$208K	﹤0.01%	4403
2017 Q4	–	Sell	-28,700	Closed	-$353K	–	5467
2017 Q3	$353K	Buy	+28,700	New	+$267K	﹤0.01%	3501
2016 Q4	–	Sell	-10,500	Closed	-$71K	–	4866
2016 Q3	$71K	Buy	+10,500	New	+$40.6K	﹤0.01%	3878
2016 Q1	–	Sell	-10,000	Closed	-$42K	–	4881
2015 Q4	$42K	Buy	+10,000	New	+$45.6K	﹤0.01%	3886

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Jane Street's ARRY Position: Q3 2019 in Review

Jane Street sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 54,982 shares — an estimated $2.55M sold.

Jane Street first reported a position in ARRY in Q2 2014 and held it in 14 quarters. The position peaked at $2.82M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Jane Street reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Jane Street sold 54,982 Array Biopharma Inc shares in Q3 2019, an estimated $2.55M.
Jane Street first reported a position in Array Biopharma Inc in Q2 2014 and held it in 14 quarters.
Jane Street's Array Biopharma Inc position peaked at $2.82M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.